Literature DB >> 29406432

Pseudomyogenic Hemangioendothelioma: Case Report and Review of the Literature.

Emily Raftopoulos1, Michael Royer2,3, Mildred Warren4, Jin Zhao5, Walter Rush3.   

Abstract

Pseudomyogenic hemangioendothelioma (PHE; epithelioid sarcoma-like hemangioendothelioma) is a rare entity, with 129 reported cases. It is a rarely metastasizing, low-grade vascular tumor that can histologically mimic epithelioid sarcoma and often presents as multiple discontinuous nodules in the extremities. PHEs characteristically and consistently show immunoreactivity for cytokeratins and endothelial markers. We present a case in the thigh of a 65-year-old-man with a 3-month history of painful lesions in the dermis and review the published literature. In our case, the lesion exhibited the characteristic histologic findings and immunoprofile of a PHE: a solid proliferation of spindled to epithelioid cells with abundant eosinophilic cytoplasm and frequent rhabdoid cells. Cytologic atypia and mitotic figures were inconspicuous. The tumor cells were immunoreactive for CD31, ERG, AE1/3, and CK7 and negative for D2-40, P53, HMB45, desmin, CD34, SMA, EMA, and S100 protein. A balanced reciprocal translation between chromosomes 7 and 19 was present; this translocation seems unique to PHE. PHE is a unique and commonly misdiagnosed entity; therefore, we review the literature to describe the characteristics of this tumor.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29406432     DOI: 10.1097/DAD.0000000000001104

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  5 in total

1.  The clinicopathological spectrum of pseudomyogenic hemangioendothelioma: report of an additional series with review of the literature.

Authors:  Yuefang Sun; Ming Zhao; I Weng Lao; Lin Yu; Jian Wang
Journal:  Virchows Arch       Date:  2020-01-24       Impact factor: 4.064

2.  Pseudomyogenic Hemangioendothelioma in a 30-Year-Old Man: A Rare Case Report.

Authors:  Chao-Yu Liao; Chao-Kuei Juan; Chi-Shun Yang; Yi-Ju Chen
Journal:  Ann Dermatol       Date:  2019-08-30       Impact factor: 1.444

3.  Pazopanib as Treatment Option for Pseudomyogenic Hemangioendothelioma: A Case Report.

Authors:  Ali Alhanash; Mohamed Aseafan; Jean Atallah
Journal:  Cureus       Date:  2022-05-23

Review 4.  Malignant Superficial Mesenchymal Tumors in Children.

Authors:  Philippe Drabent; Sylvie Fraitag
Journal:  Cancers (Basel)       Date:  2022-04-26       Impact factor: 6.575

5.  Painful, erythematous, and ulcerated nodules on the thigh.

Authors:  Austin D Jones; John J Fowler
Journal:  JAAD Case Rep       Date:  2022-03-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.